May 13, 2020: Prodrome Sciences is continuing operations during COVID-19. Our top priority is the safety and well-being of our employees, suppliers, and customers.

Dr. Goodenowe presents at the Dementia Prevention Conference in Japan

October 24, 2019

Plasmalogen research and clinical trial presented at the Dementia Prevention Conference in Japan

Dr. Goodenowe, Founder of Prodrome Sciences, presented his research on plasmalogens and neurodegeneration and the strong clinical data supporting plasmalogen supplementation as a strategy to prevent and treat dementia and to increase longevity. He presented Prodrome Sciences' Prodrome-Neuro Plasmalogen Oil dietary supplement product currently available for research use only, which will be studied in Alzheimer's patients with support from a grant from the Alzheimer's Association.

Contact us for more information.

Keep in touch

©2021 Prodrome Sciences Inc.